drugset / Trial / NCT06249113

Effectiveness of Continous Adjuvant Lidocaine on General Anaesthesia on Tumor Craniotomy Surgery

NCT06249113 ↗

Completed 60 enrolled Indonesia University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to investigate the effect of adjuvant continuous lidocaine in General Anesthesia on Depth of Anesthesia (qCON), Pain Response (qNOX), and Blood Sugar Levels in Elective Primary Tumor Craniotomy Surgery

Timeline

Start
2023-01-16
Primary completion
2023-11-23
Completion
2024-01-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.